yes the 3 years is my source.. but YOY last year was 50% and prostate will be GHDX biggest Money maker.not yet rolling in Good Luck
the future is not iplex.Why dont you get a clue? NTM is the target pop.It really could be HUGE!, but the other drugs, the small CF market , honestly, you are just one correction from losing a lot of money
email said you were mentioning woman I have had relationships with in the past#$%$!!? heavens how pathetic! I can send you email about the 2 Airline stewardess in St Croix! Please post! lol
As I posted in Dec I am out of Insmed until results ,if at all.
I have made good profits with the stock INSM - a double last year and 2 triples (09 06) as
traders knew Insmed was an easy target with the likes of fud zipdorian and kvncmcdd and others guillble enough to believe slam dunk and billions.
I posted recently that the INSM chart was in an uptrend and that "powerful Institutional numbers" were indicators to this trader that the good ole days of easy money were over.
Informed experienced investors realize full well the risk as well as the possible rewards Insmeds may give.It is neither 99 cents or billions.Most of those from iplex failure days are in @ 10-11 dollars.
The biggest risk is that should NTM fail,the stock and the investment are in big trouble.I am invested in 5 biotech stocks with imho have better pipelines.
I am of the OPINION - the results odds favor something along the lines of the not so compelling but satisfactory results as was seen in CF trial. Good but not the Huge! billions! slam dunk idiocy repeated to those who are here to cheer not DD.
If NTM fully succeeds with NTM, Insmed will advance strongly,
The January effect is alive and well.
With possible Arikace results in March , there is plenty of time to trade ( not me)
Solar Coal Gold Miners Shipping Internet Stocks Foreign Stocks + hot bios.
solars bios and airlines Thanks to A - ) ICPT is beyond silly
ps- Cathy I pay no attention to the resident clowns- a lot of my thread looks like someone used white out - )
stxs setup .... surfs up soo and the fugjhg!! water is COLD Good Luck
the difference of course is that if NTM disappoints Insmed will suffer a huge loss as opposed to other bios with deeper pipelines-thats the difference.Place your bets
of course ARDM would hhave been a 27 dollar stock had they reversed split the stock to death.92 % insider owned and More square footage space in their offices! In Phase 3
Kind of amazing anyone would question Mr Lewis's handling of the financial side of Insmed....Good results is another story,don't confuse the two.The chart INSM has been a short reversal the last two days,news will throw it all out the window.There is nothing wrong with taking money off the table .Place your bets,understanding that it is just that. I bet the results like CF are good but not compelling enough to skip a Phase3 ,but I am a chartist playing the odds. Good Luck
Yes thats exactly what I was doing! Traders tomorrow.Go ! Chargers!.....am I the only one?-(
The FDA has not in the past done anything to undermine their supremacy,so youstupid not stupid. .Insmed can however use NTM data if they decide on a Phase3 trial.in the US for that indication (CF).Will has stated this but that was before the results showed Arikace will just be another drug in rotation.A few posters have posted examples of stocks they owned where the FDA said after a EU trial- fine- now do one here under OUR rules.Will has admitted the EU trial was a quickie.Bet the FDA wants a longer one.
Comic relief - ) GOGO DRYS
Will be leaving tonight for snow and Christmas with family Merry Christmas!
jd39souza98 - another clowwn iD...bandehcamilo is surely the best trader here.
I am +114% YTD ( with a current short position +3% on paper).If you were simply a long this year you are up about the same, but most of the longs here are those who are in avg about ten dollars( a dollar) given their IPlex losses so "longs from Iplex are up about 50% (assuming you avg down a bit) in the last 4.5 years.......... 12 % a year is a good return. Trading upstart bios always does far better than buy and hold.